Cited by 649Schizophrenia research and treatmentMental Health and PsychiatryBipolar Disorder and Treatment

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort

Wiersma, D., Nienhuis, F. J., Slooff, C. J., Giel, R.·1998·Schizophrenia Bulletin

DOI 10.1093/oxfordjournals.schbul.a033315

Open this paper in CoChat — free account

Abstract

Data are presented on the 15-year natural course of schizophrenia and other nonaffective functional psychoses in a cohort of 82 first-contact cases from a circumscribed area in the Netherlands. The subjects were suffering from functional psychosis with International Classification of Diseases-Ninth Revision (ICD-9) diagnoses 295, 297, or 298.3-9 (broad definition of schizophrenia) on entry. Standardized assessments of psychopathology, psychological impairments, negative symptomatology, social disability, and use of mental healthcare were used. The study reveals a pattern of chronicity and relapses with a high risk of suicide: Two-thirds of the subjects had at least one relapse and after each relapse 1 of 6 subjects did not remit from the episode; 1 of 10 committed suicide; and 1 of 7 had at least one episode with affective psychotic symptoms that started on average 6 years after the onset of the schizophrenic disorder. Diagnoses were reclassified in five patients, according to DSM-III-R criteria for a bipolar disorder. The predictive power--in terms of time in psychosis and in partial or full remission--of demographic, illness, and treatment variables at onset of the illness was very limited. Insidious onset and delays in mental health treatment are risk factors that predict a longer duration of first or subsequent episodes. The importance of mental health treatment in regard to outcome is probably subject to change because an early warning and intervention strategy could prevent further damage and deterioration. Our data support the need for an adequate relapse prevention program as a priority for our mental health services.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.schbul.a033315

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders
Bell, C. C. (1994) · JAMA · doi:10.1001/jama.1994.03520100096046 · Cited by 2,608
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
One hundred years of schizophrenia: a meta-analysis of the outcome literature
Hegarty, J. D., Baldessarini, R. J., Tohen, M. F., WATERNAUX, C. M., & Oepen, G. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1409 · Cited by 771
A Selective Review of Recent North American Long-term Followup Studies of Schizophrenia
McGlashan, T. H. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.4.515 · Cited by 551
Search for the Causes of Schizophrenia
(1995) · Springer eBooks · doi:10.1007/978-3-642-79429-2 · Cited by 510
Schizophrenia : manifestations, incidence and course in different cultures
Zhablenski, A. V. (1992) · Cambridge University Press eBooks · Cited by 506
Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman, J. A. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820170047006 · Cited by 446

Show all 38 references

Research works printed but not linked: 4

Eaton, W.W.; Bilker, W.; Haro, J.M.; Hen-man, H.; Mortensen, P.B.; Freeman, H.; and Burgess, P. Long-term course of hospitalization for schizophrenia: Part II. Change with passage of time. Schizophrenia Bulletin, 18(2):229-241, 1992.
Engelhardt, D.M.; Rosen, B.; Feldman, J.; Engelhardt, J.A.; and Cohen, P. A 15-year follow-up of 646 schizo- phrenic outpatients. Schizophrenia Bulletin, 8(3):493- 503, 1982.
Hogarty, G.E. Prevention of relapse in schizophrenia. Journal of Clinical Psychiatry, 54(Suppl. 3):18-23, 1993.
Wing, J.K.; Cooper, J.E.; and Sartorius, N. The Measure- ment and Classification of Psychiatric Symptoms. Cambridge, England: Cambridge University Press, 1974.

Sorted by citations

Items 101–200 of 644

Status of Patients With First-Episode Psychosis After One Year of Phase-Specific Community-Oriented Treatment
MALLA, A. K., Norman, R. M. G., Manchanda, R., McLean, T. S., Harricharan, R., Cortese, L., Townsend, L. A., & Scholten, D. J. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.4.458 · Cited by 75
Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse
Eisner, E., Drake, R. J., Berry, N., Barrowclough, C., Emsley, R., Machin, M., & Bucci, S. (2019) · JMIR mHealth and uHealth · doi:10.2196/11568 · Cited by 73
Suicidal Behavior in Schizophrenia and Schizoaffective Disorder: Examining the Role of Depression
Harkavy‐Friedman, J., Nelson, E. A., Venarde, D. F., & Mann, J. J. (2004) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.34.1.66.27770 · Cited by 74
Early Intervention in Psychosis
Reading, B., & Birchwood, M. J. (2005) · Disease Management & Health Outcomes · doi:10.2165/00115677-200513010-00006 · Cited by 77
Prediction of a single psychotic episode: A 7.5-year, prospective study in first-episode psychosis
Álvarez‐Jiménez, M., Gleeson, J., Henry, L. P., Harrigan, S., Harris, M., Amminger, G. P., Killackey, E. J., Yung, A. R., Herrman, H., Jackson, H. J., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.020 · Cited by 73
Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia
Kim, H. O., Seo, G. H., & Lee, B. C. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-019-0254-2 · Cited by 74
Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia
Zugman, A., Gadelha, A., Assunção-Leme, I. B., Sato, J. R., Ota, V., Rocha, D., Mari, J. D. J., Belangero, S. I., Bressan, R. A., Brietzke, E. M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.002 · Cited by 72
Effectiveness of the Information Technology-Aided Program of Relapse Prevention in Schizophrenia (ITAREPS)
Španiel, F., HRDLIČKA, J., Novák, T., Kožený, J., Höschl, C., Mohr, P., & Motlová, L. B. (2012) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000416017.45591.c1 · Cited by 71
Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis
Polese, D., Fornaro, M., Palermo, M., Luca, V. D., & de Bartolomeis, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00210 · Cited by 78
A single blind randomized controlled trial of cognitive behavioural therapy in a help-seeking population with an At Risk Mental State for psychosis: the Dutch Early Detection and Intervention Evaluation (EDIE-NL) trial
Rietdijk, J., Dragt, S., Klaassen, R. M. C., Ising, H. K., Nieman, D. H., Wunderink, L., Delespaul, P., Cuijpers, P. J., LINSZEN, D. H., & van der Gaag, M. (2010) · Trials · doi:10.1186/1745-6215-11-30 · Cited by 68
Operationalization of the SAMHSA model of recovery: a quality of life perspective
Chiu, M. Y.-L., Ho, W. W. N., Lo, W. T.-L., & Yiu, M. G. C. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9555-2 · Cited by 68
A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosis
Gleeson, J., Álvarez‐Jiménez, M., Cotton, S., Parker, A. G., & Hetrick, S. E. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1073 · Cited by 69
E-Prevention: Advanced Support System for Monitoring and Relapse Prevention in Patients with Psychotic Disorders Analyzing Long-Term Multimodal Data from Wearables and Video Captures
Zlatintsi, A., Filntisis, P. P., Garoufis, C., Efthymiou, N., Maragos, P. A., Menychtas, A., Maglogiannis, I. G., Tsanakas, P. D., Sounapoglou, T., Kalisperakis, E., et al. (2022) · Sensors · doi:10.3390/s22197544 · Cited by 72
Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study
Cechnicki, A., Cichocki, Ł., Kalisz, A., Błądziński, P., Adamczyk, P., & Franczyk-Glita, J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.05.046 · Cited by 68
Pharmacological Management of First-Episode Schizophrenia and Related Nonaffective Psychoses
Bradford, D. W., Perkins, D. O., & Lieberman, J. A. (2003) · Drugs · doi:10.2165/00003495-200363210-00001 · Cited by 67
The course of parental expressed emotion and psychotic episodes after family intervention in recent-onset schizophrenia. A longitudinal study
Lenior, M. E., Dingemans, P. M. A. J., Schene, A. H., Hart, A. A. M., & LINSZEN, D. H. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00305-x · Cited by 67
Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study
Fraguas, D., Rey, A., Moreno, C., Castro‐Fornieles, J., Graell, M., Otero, S., González-Pinto, A. M., Moreno, D. M., Baeza, I., Martínez‐Cengotitabengoa, M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.018 · Cited by 66
Cantabria First-Episode Schizophrenia Study: three-year follow-up
Vázquez‐Barquero, J. L., Cuesta, M. J. L., Castanedo, S. H., Lastra, I., Herrán, A., & Dunn, G. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.174.2.141 · Cited by 64
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity
Möller, H., Jäger, M., Riedel, M. J., Obermeier, M., Strauß, A., & Ronald Bottlender, A. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0117-y · Cited by 63
Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort
Lauronen, E., Miettunen, J., Veijola, J. M., Karhu, M., Jones, P. B., & Isohanni, M. K. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2006.07.001 · Cited by 62
Early intervention in schizophrenia and related disorders: advantages and pitfalls
Malla, A., & Norman, R. (2002) · Current Opinion in Psychiatry · doi:10.1097/00001504-200201000-00004 · Cited by 63
Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: A first-episode psychosis study
Tang, J. Y. ‐., Chang, W. C., Hui, C. L. M., Wong, G. H. Y., Chan, S. K. W., Lee, E. H. M., Yeung, W. S., Wong, C., Tang, W.-N., Chan, W.-F., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.022 · Cited by 61
Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth
Abidi, S., Mian, I. A., Ortega, I., Lecomte, T., Raedler, T. J., Jackson, K., Jackson, K., Pringsheim, T. M., & Addington, D. E. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743717720197 · Cited by 66
Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?
Bora, E., Yücel, M., Fornito, A., Berk, M., & Pantelis, C. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01230.x · Cited by 61
Management of Early Psychosis in a Generic Adult Mental Health Service
Yung, A., Organ, B., & Harris, M. (2003) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1046/j.1440-1614.2003.01196.x · Cited by 66
Women and schizophrenia
Abel, K. M., Goldstein, J. M., Stanley, N., & Castle, D. J. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107045132.023 · Cited by 61
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy
Alphs, L. D., Nasrallah, H. A., Bossie, C. A., Fu, D., Gopal, S., Hough, D., & Turkoz, I. (2016) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000125 · Cited by 60
Benefits of Enriched Intervention Compared with Standard Care for Patients with Recent-Onset Psychosis: A Metaanalytic Approach
Harvey, P., Lepage, M., & MALLA, A. K. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200709 · Cited by 59
Rates and Predictors of Relapse in First-Episode Psychosis: An Australian Cohort Study
Brown, E., Bedi, G., McGorry, P. D., & O'Donoghue, B. N. (2020) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaa017 · Cited by 57
Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics
Hargarter, L., Chérubin, P., Bergmans, P., Keim, S., Rancāns, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., & Schreiner, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.11.006 · Cited by 57
Interrogating the Meaning of “Culture” in the WHO International Studies of Schizophrenia
Hopper, K. J. (2003) · Cambridge University Press eBooks · doi:10.1017/cbo9780511616297.005 · Cited by 57
The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up
Španiel, F., Vohlídka, P., Kožený, J., Novák, T., Hrdlička, J., Motlová, L. B., Cermak, J. K., & Höschl, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01903.x · Cited by 56
Hallucination focused integrative treatment improves quality of life in schizophrenia patients
Wiersma, D., Jenner, J. A., Nienhuis, F. J., & van, D. W. G. (2004) · Acta Psychiatrica Scandinavica · doi:10.1046/j.0001-690x.2003.00237.x · Cited by 56
Self-citation
Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment
Altamura, A. C., Bobo, W. V., & Meltzer, H. Y. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3280de2c7f · Cited by 56
Public knowledge, beliefs and attitudes towards patients with schizophrenia: Buenos Aires
Leiderman, E. A., Vázquez, G. H., Berizzo, C., Bonifácio, A., Bruscoli, N., Capria, J. I., Ehrenhaus, B., Guerrero, M., Guerrero, M., Lolich, M., et al. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0196-0 · Cited by 58
Are adult stressful life events associated with psychotic relapse? A systematic review of 23 studies
Martland, N., Martland, R., Cullen, A. E., & Bhattacharyya, S. (2020) · Psychological Medicine · doi:10.1017/s0033291720003554 · Cited by 54
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: Assessing courses, types and time stability of diagnostic classification
Möller, H. ‐., Jäger, M., Riedel, M. J., Obermeier, M., Strauß, A., & Bottlender, R. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.04.012 · Cited by 58
Maintenance ECT in schizophrenia: A systematic review
Ward, H. B., Szabo, S. T., & Rakesh, G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.033 · Cited by 58
Early Intervention for psychosis
Marshall, M., & Rathbone, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004718.pub2 · Cited by 57
Long-acting risperidone compared with oral olanzapine and haloperidol depot in schizophrenia: a Belgian cost-effectiveness analysis
Graeve, D. D., Smet, A., Mehnert, A., Caleo, S., Miadi-Fargier, H., Jasso-Mosqueda, G., Lecompte, D., & Peuskens, J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523001-00004 · Cited by 53
Prediction of twelve‐month service disengagement from an early intervention in psychosis service
Turner, M., Smith‐Hamel, C., & Mulder, R. (2007) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2007.00039.x · Cited by 53
Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report
Eisner, E., Bucci, S., Berry, N., Emsley, R., Barrowclough, C., & Drake, R. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.04.003 · Cited by 52
Treating Psychosis: Is There More to Early Intervention Than Intervening Early?
MALLA, A. K., & Norman, R. M. G. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600710 · Cited by 52
Agreeableness and Neuroticism as Predictors of Relapse After First-Episode Psychosis
Gleeson, J., Rawlings, D., Jackson, H. J., & McGorry, P. D. (2005) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000154841.99550.d3 · Cited by 52
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
Haddad, P. M., & Correll, C. U. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2181073 · Cited by 58
Neurocognitive development in first episode psychosis 5years follow-up: Associations between illness severity and cognitive course
Barder, H. E., Sundet, K. S., Rund, B. R., Evensen, J. H., Haahr, U., Hegelstad, W. T. V., Joa, I., Johannessen, J. O., Langeveld, H., Larsen, T. K., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.06.016 · Cited by 51
Lifetime relapse and its associated factors among people with schizophrenia spectrum disorders who are on follow up at Comprehensive Specialized Hospitals in Amhara region, Ethiopia: a cross-sectional study
Demeke, S. M., Mossie, T. B., Mekonen, T., & Menberu, M. (2021) · International Journal of Mental Health Systems · doi:10.1186/s13033-021-00464-0 · Cited by 51
The readmission rate and medical cost of patients with schizophrenia after first hospitalization — A 10-year follow-up population-based study
Chi, M. H., Hsiao, C. Y., Chen, K. C., Lee, L.-T., Tsai, H. C., Lee, I. H., Chen, P. S., & Yang, Y. K. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.025 · Cited by 50
Understanding factors influencing substance use in people with recent onset psychosis: A qualitative study
Lobbana, F., Barrowclough, C., Jeffery, S., Bucci, S., Taylor, K. A., Mallinson, S., Fitzsimmons, M., & Marshall, M. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2009.12.026 · Cited by 50
Improving Treatment Adherence in Your Patients with Schizophrenia
Cañas, F., Alptekın, K., Azorin, J. M., Dubois, V., Emsley, R. A., Garcı́a, A. G., Gorwood, P. A. P. M., Haddad, P. M., Naber, D., Olivares, J. M., et al. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-012-0047-8 · Cited by 50
The relapse rate and predictors of relapse in patients with first‐episode psychosis following discontinuation of antipsychotic medication
Capite, S. D., Upthegrove, R., & Mallikarjun, P. K. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12385 · Cited by 49
Weight gain associated with psychotropic drugs
Masand, P. S. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.3.377 · Cited by 49
Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses
Geerts, P., Martinez, G., & Schreiner, A. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-58 · Cited by 48
Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors
Huber, C. G., Naber, D., & Lambert, M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.12.2027 · Cited by 51
Clinical factors related to schizophrenia relapse
Porcelli, S., Bianchini, O., de Girolamo, G., Aguglia, E., Crea, L., & Serretti, A. (2016) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2016.1149195 · Cited by 50
The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
Kinon, B. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00757 · Cited by 47
Fear of recurrence: Results of a randomized trial of relapse detection in schizophrenia
Gumley, A. I., MacBeth, A., Reilly, J. D., O'Grady, M., White, R. G., McLeod, H., Schwannauer, M., & Power, K. G. (2015) · British Journal of Clinical Psychology · doi:10.1111/bjc.12060 · Cited by 46
Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)
Pelayo‐Terán, J. M., Gajardo-Galán, V., de la Foz, V. O., Martínez‐García, O., Tabarés‐Seisdedos, R., Crespo‐Facorro, B., & Ayesa‐Arriola, R. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0740-3 · Cited by 46
Resistance is not futile: treatment-refractory schizophrenia – overview, evaluation and treatment
Faden, J., & Citrome, L. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1543409 · Cited by 44
Predictors of outcome in first-episode schizophrenia over the first 4 years of illness
Whitty, P., Clarke, M., McTigue, O., Browne, S., Kamali, M., Kinsella, A., Larkin, C., & O’Callaghan, E. (2008) · Psychological Medicine · doi:10.1017/s003329170800336x · Cited by 45
Schizophrenia: Improving Outcome
Bustillo, J., Lauriello, J., & Keith, S. J. (1999) · Harvard Review of Psychiatry · doi:10.3109/10673229909000335 · Cited by 45
Intervention for Adolescents With Early-Onset Psychosis and Their Families: A Randomized Controlled Trial
Calvo, A., Moreno, M., Ruíz-Sancho, A., Rapado‐Castro, M., Moreno, C., Sánchez‐Gutiérrez, T., Arango, C., & Mayoral, M. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.04.004 · Cited by 44
Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health
Cotton, S., Filia, K., Ratheesh, A., Pennell, K., Goldstone, S. D., & McGorry, P. D. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1140-0 · Cited by 47
Comparison of rehospitalization rates and associated costs among patients with schizophrenia receiving paliperidone palmitate or oral antipsychotics
Lafeuille, M., Grittner, A. M., Fortier, J., Muser, E., Fasteneau, J., Duh, M. S., & Lefèbvre, P. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140219 · Cited by 44
Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study
Ran, M., Xiao, Y., CHUI, C. H.-K., Hu, X., Yu, Y.-H., Peng, M., Mao, W.-J., Liu, B., Eric, Y.-H. C., & Chan, C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.06.043 · Cited by 44
Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
Rodrígues-Amorím, D., Baltanás, T. R., Vallejo-Curto, M. D. C., Rodríguez-Jamardo, C., Heras, E. D. L., Barreiro-Villar, C., Blanco-Formoso, M., Fernández-Palleiro, P., Álvarez-Ariza, M., López, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71060-4 · Cited by 44
Duration of untreated psychosis and the long-term course of schizophrenia
de Haan, L., van der Gaag, M., & WOLTHAUS, J. E. D. (2000) · European Psychiatry · doi:10.1016/s0924-9338(00)00234-0 · Cited by 44
Early detection and treatment delay: implications for outcome in early psychosis
McGorry, P. D., Krstev, H., & Harrigan, S. (2000) · Current Opinion in Psychiatry · doi:10.1097/00001504-200001000-00007 · Cited by 44
Polyunsaturated fatty acid supplementation for schizophrenia
Joy, C., Mumby-Croft, R., & Joy, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001257 · Cited by 45
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? results of a retrospective study
Primavera, D., Bandecchi, C., Lepori, T., Sanna, L., Nicotra, E. F., & Carpiniello, B. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-21 · Cited by 43
Trauma and psychosis: theoretical and clinical implications
Scandinavica, A. P., Morrison, A. P., Read, J., & Turkington, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00644.x · Cited by 43
Clinically useful assessments: substance use and comorbid psychiatric disorders
Carey, K. B. (2002) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(02)00039-6 · Cited by 43
Pharmacotherapy of first-episode psychosis
Lambert, M., Conus, P., Lambert, T. J. R., & McGorry, P. D. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.5.717 · Cited by 43
Depressive symptoms during first episode psychosis and functional outcome: A systematic review and meta-analysis
McGinty, J., & Upthegrove, R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.011 · Cited by 47
Duration of untreated psychosis: a proposition regarding treatment definition
Polari, A. R., Lavoie, S., Sarrasin, P., Pellanda, V., Cotton, S., & Conus, P. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00308.x · Cited by 42
Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study
Correll, C. U., Kohegyi, E., Zhao, C. Y., Baker, R. A., McQuade, R. D., Salzman, P. M., Sanchez, R., Nyilas, M., & Carson, W. H. (2017) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2017.06.013 · Cited by 41
Negative symptoms of psychosis: A life course approach and implications for prevention and treatment
Lyne, J., O'Donoghue, B. N., Roche, E., Renwick, L., Cannon, M. D., & Clarke, M. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12501 · Cited by 41
Suicide in Recent Onset Psychosis Revisited: Significant Reduction of Suicide Rate over the Last Two Decades — A Replication Study of a Dutch Incidence Cohort
Castelein, S., Liemburg, E. J., de Lange, J. S., van Es, F. D., Visser, E., Aleman, A., Bruggeman, R., & Knegtering, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129263 · Cited by 40
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Barnes, T. R. E., Leeson, V. C., Paton, C., Marston, L., Davies, L. M., William, W., Osborn, D., Kumar, R., Keown, P., Zafar, R., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21490 · Cited by 39
Heterogeneity of outcomes in schizophrenia
Ruggeri, M., Lasalvia, A., Tansella, M., Bonetto, C., Abate, M., Thornicroft, G., Allevi, L., & Ognibene, P. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.184.1.48 · Cited by 40
First-Episode Psychosis: A Comparative Review of Diagnostic Evolution and Predictive Variables in Adolescents versus Adults
Menezes, N. M., & Milovan, E. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500803 · Cited by 39
Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial
Boonstra, G., Burger, H., Grobbee, D. E., & Kahn, R. S. (2011) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2010.534801 · Cited by 38
A prospective flexible-dose study of paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents.
Schreiner, A., Bergmans, P., Cherubin, P., Keim, S., Rancāns, E., Bez, Y., Parellada, E., Carpiniello, B., Vidailhet, P., & Hargarter, L. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.08.014 · Cited by 42
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis
Fraguas, D., Merchán‐Naranjo, J., Rey, A., Castro‐Fornieles, J., González-Pinto, A. M., Rapado‐Castro, M., Pina‐Camacho, L., Díaz‐Caneja, C. M., Graell, M., Otero, S., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.038 · Cited by 39
Specialised early intervention teams for recent-onset psychosis
Puntis, S., Minichino, A., Crescenzo, F. D., Harrison, R., Cipriani, A., & Lennox, B. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013288.pub2 · Cited by 37
Long-term clinical course and outcome of schizophrenia in rural Ethiopia: 10-year follow-up of a population-based cohort
Shibre, T., Medhin, G., Alem, A., Kebede, D., Teferra, S., Jacobsson, L. H., Kullgren, G., Hanlon, C., & Fekadu, A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.10.053 · Cited by 37
Effectiveness of Information Technology Aided Relapse Prevention Programme in Schizophrenia excluding the effect of user adherence: A randomized controlled trial
Komatsu, H., Sekine, Y., Okamura, N., Kanahara, N., Okita, K., Matsubara, S., Hirata, T., Komiyama, T., Watanabe, H., Minabe, Y., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.007 · Cited by 37
Elevated environmental PM2.5 increases risk of schizophrenia relapse: Mediation of inflammatory cytokines
Gao, J., Wei, Q., Pan, R., Yi, W., Xu, Z., Duan, J., Tang, C., He, Y., Liu, X., Song, S., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.142008 · Cited by 37
Clinical and treatment predictors of relapse during a three-year follow-up of a cohort of first episodes of schizophrenia.
Bioque, M., Mezquida, G., Amoretti, S., García-Rizo, C., López-Ilundain, J., Díaz-Caneja, C., Zorrilla, I., Mané, A., Rodríguez-Jiménez, R., Corripio, I., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.02.026 · Cited by 30
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT
Gumley, A. I., Bradstreet, S., Ainsworth, J. D., Allan, S., Álvarez‐Jiménez, M., Birchwood, M. J., Briggs, A. H., Bucci, S., Cotton, S., Engel, L., et al. (2022) · Health Technology Assessment · doi:10.3310/hlze0479 · Cited by 41
Relapse in schizophrenia: Definitively not a bolt from the blue
Španiel, F., Bakštein, E., Anýž, J., Hlinka, J., Sieger, T., Hrdlicka, J., Görnerová, N., & Höschl, C. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.044 · Cited by 36
Optimizing psychosocial interventions in first-episode psychosis: current perspectives and future directions
Breitborde, N. J. K., Moe, A. M., Ered, A., Ellman, L. M., & Bell, E. K. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s111593 · Cited by 36
A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia
Hui, C. L. M., Lam, B. S. T., Lee, E. H. M., Chan, S. K. W., Chang, W. C., Suen, Y. N., & Chen, E. Y. H. (2019) · International Review of Psychiatry · doi:10.1080/09540261.2019.1613965 · Cited by 40
Is the course and outcome of schizophrenia better in the ‘developing’ world?
Kulhara, P., Shah, R., & Grover, S. (2009) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2009.04.003 · Cited by 36
Rate and predictors of non‐response to first‐line antipsychotic treatment in first‐episode schizophrenia
Chiliza, B., Asmal, L., Kilian, S., Phahladira, L., & Emsley, R. A. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2469 · Cited by 36
Duration of Untreated Psychosis: Are We Ignoring the Mode of Initial Development?
Møller, P. (2001) · Psychopathology · doi:10.1159/000049274 · Cited by 36
The treatment of schizophrenia: Can we raise the standard of care?
Catts, S. V., & O’Toole, B. I. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416672725 · Cited by 35
Maximizing the synergy between pharmacotherapy and psychosocial therapies for schizophrenia
Lauriello, J., Lenroot, R., & Bustillo, J. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00017-5 · Cited by 35
Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments
Haandel, L. B.-V., Slooff, C. J., & van den Bosch, R. J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00089.x · Cited by 35
Self-citation
Glucocorticosteroids Associated With a Decreased Risk of Psychosis
Laan, W., Smeets, H. M., de Wit, N. J., Kahn, R. S., Grobbee, D. E., & Burger, H. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a44575 · Cited by 34

Authors: Wiersma, D., Nienhuis, F. J., Slooff, C. J., & Giel, R.
Affiliations: University of Groningen (NL)
Corresponding author: Wiersma, D.
ORCID: Giel, R.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 1998-01-01
Volume: 24
Issue: 1
Pages: 75-85
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/oxfordjournals.schbul.a033315
OpenAlex: W2121119246
Cited by: 649
References: 38
Citations by year: 2026: 8 · 2025: 12 · 2024: 14 · 2023: 14 · 2022: 18 · 2021: 17 · 2020: 56 · 2019: 38 · 2018: 24 · 2017: 26 · 2016: 62 · 2015: 22 · 2014: 34 · 2013: 28 · 2012: 15
FWCI: 8.73
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: schizophrenia
MeSH terms: Suicide Prevention, Activities of Daily Living, Adolescent, Adult, Chronic Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Netherlands, Psychiatric Status Rating Scales, Recurrence, Rehabilitation, Vocational, Schizophrenia, Schizophrenic Psychology, Suicide, Cohort Studies, Incidence, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks